Works matching IS 15228517 AND DT 2016 AND VI 18 AND IP 9
Results: 20
Response to: “Prognostic relevance of epilepsy at presentation in lower-grade gliomas”.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1327, doi. 10.1093/neuonc/now161
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1195, doi. 10.1093/neuonc/now173
- By:
- Publication type:
- Article
Announcements.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1330, doi. 10.1093/neuonc/now172
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1329, doi. 10.1093/neuonc/now142
- Publication type:
- Article
Prognostic relevance of epilepsy at presentation in lower-grade gliomas.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1326, doi. 10.1093/neuonc/now140
- By:
- Publication type:
- Article
Phase 1 trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1319, doi. 10.1093/neuonc/now047
- By:
- Publication type:
- Article
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1313, doi. 10.1093/neuonc/now046
- By:
- Publication type:
- Article
AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1304, doi. 10.1093/neuonc/now035
- By:
- Publication type:
- Article
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1297, doi. 10.1093/neuonc/now033
- By:
- Publication type:
- Article
MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1288, doi. 10.1093/neuonc/now044
- By:
- Publication type:
- Article
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1278, doi. 10.1093/neuonc/now031
- By:
- Publication type:
- Article
Components of the eIF4F complex are potential therapeutic targets for malignant peripheral nerve sheath tumors and vestibular schwannomas.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1265, doi. 10.1093/neuonc/now032
- By:
- Publication type:
- Article
Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1253, doi. 10.1093/neuonc/now034
- By:
- Publication type:
- Article
Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1242, doi. 10.1093/neuonc/now043
- By:
- Publication type:
- Article
Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1230, doi. 10.1093/neuonc/now030
- By:
- Publication type:
- Article
Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1219, doi. 10.1093/neuonc/now024
- By:
- Publication type:
- Article
Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1209, doi. 10.1093/neuonc/now051
- By:
- Publication type:
- Article
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1199, doi. 10.1093/neuonc/now058
- By:
- Publication type:
- Article
PET imaging in glioma: is it time for mainstream practice?
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1193, doi. 10.1093/neuonc/now134
- By:
- Publication type:
- Article
Corticosteroids for peritumoral edema: time to overcome our addiction?
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 9, p. 1191, doi. 10.1093/neuonc/now167
- By:
- Publication type:
- Article